The LONG LIMB trial supplementary data

Alexander Dimitri Miras; Anna Kamocka; Tricia Tan; Belén Pérez-Pevida; Harvinder Chahal; Krishna Moorthy; Sanjay Purkayastha; Ameet Patel; Anne Margot Umpleby; Gary Frost; Stephen Robert Bloom; Ahmed Rashid Ahmed; Francesco Rubino

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Miras AD, Kamocka A, Tan T, et al. Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT. Southampton (UK): NIHR Journals Library; 2021 Feb. (Efficacy and Mechanism Evaluation, No. 8.3.)

Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT.

Show details

Contents

< Prev Next >

Appendix 3The LONG LIMB trial supplementary data

Characteristic	Time point
	Baseline		1 year postoperatively
	Long limb RYGB (n = 26)	Standard limb RYGB (n = 27)	Long limb RYGB (n = 26)	Standard limb RYGB (n = 27)
Number of glucose-lowering medications at baseline (classes)
1	11% (3)	4% (1)	0	0
2	27% (7)	44% (12)	0	0
3	35% (9)	26% (7)	1	0
4	27% (7)	19% (5)	0	0
5	0% (0)	7% (2)	0	0
Classes of medications
Biguanides	92% (24)	93% (25)	1	0
SGLT-2 inhibitors	54% (14)	56% (15)	1	0
Sulfonylurea	50% (13)	48% (13)	0	0
GLP-1 agonists	35% (9)	15% (4)	1	0
DPP-4 inhibitors	31% (8)	52% (14)	0	0
Insulin	15% (4)	15% (4)	0	0
Total	72	75

: DPP-4, dipeptidyl peptidase 4; SGLT-2, sodium–glucose transport protein 2.
: Note
: Categorical data presented as a percentage (n).

Copyright © Queen’s Printer and Controller of HMSO 2021. This work was produced by Miras et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.

Bookshelf ID: NBK567574

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Miras AD, Kamocka A, Tan T, et al. Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT. Southampton (UK): NIHR Journals Library; 2021 Feb. (Efficacy and Mechanism Evaluation, No. 8.3.) Appendix 3, The LONG LIMB trial supplementary data.
PDF version of this title (12M)

Other titles in this collection

Efficacy and Mechanism Evaluation

Recent Activity

Clear Turn Off Turn On

The LONG LIMB trial supplementary data - Long limb compared with standard limb R...
The LONG LIMB trial supplementary data - Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Bookshelf

Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT.

Appendix 3The LONG LIMB trial supplementary data

Views

Other titles in this collection

Recent Activity